Table 1.
Clinical features of the enrolled patients.
| Features | Value | ||
|---|---|---|---|
| Patients with confirmed COVID-19 | |||
| Age, median (IQR), years | 62 (45–71) | ||
| Male, n (%) | 15 (50) | ||
| Signs and symptoms at admission, n (%) | |||
| Fever | 25 (83.3) | ||
| Cough | 19 (63.3) | ||
| Fatigue | 9 (30) | ||
| Dyspnea | 8 (26.70) | ||
| Myalgia | 6 (20) | ||
| Anorexia | 5 (16.7) | ||
| Headache | 3 (10) | ||
| Pharyngodynia | 1 (3.3) | ||
| Nausea and vomiting | 1 (3.3) | ||
| Stomach ache | 1 (3.3) | ||
| No signs or symptoms | 1 (3.3) | ||
| Underlying chronic diseases, n (%) | |||
| Hypertension | 11 (36.7) | ||
| Mellitus | 4 (13.3) | ||
| Hyperlipemia | 2 (6.7) | ||
| Coronary heart disease | 2 (6.7) | ||
| Arrhythmia | 1 (3.3) | ||
| Bronchiectasis | 1 (3.3) | ||
| Chronic obstructive pulmonary disease | 1 (3.3) | ||
| Clinical classification, (%) | |||
| Mild type | 15 (50) | ||
| Severe type | 15 (50) | ||
| Clinical stage, n (%) | |||
| Early stage | 13 (43.3) | ||
| Progressive stage | 15 (50) | ||
| Recovery stage | 2 (6.7) | ||
| Patients without COVID-19 | |||
| Age, median (IQR), years | 37 (30–56) | ||
| Male, n (%) | 38 (62.3) | ||